In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Galderma S.A.

http://www.galderma.com

Latest From Galderma S.A.

Nestle, Bullish On Palforzia, To Buy Remainder Of Aimmune

Since Palforzia likely will be the only peanut allergy drug on market for some time, Nestle announces it will pay about $2.6bn to acquire the 80% of Aimmune it doesn’t own.

M & A Deals

Dermavant's Tapinarof Could Bring Innovation To Topical Psoriasis Market

CEO Todd Zavodnick said the non-steroidal topical cream is poised to become a blockbuster brand.

Dermatology Clinical Trials

UK’s COVID-19 Ventilator Challenge Scores First Success

UK anesthesia products manufacturer Penlon has received UK regulatory approval for a new ventilator, having taken up the government’s Ventilator Challenge in response to the COVID-19 pandemic.

United Kingdom Coronavirus COVID-19

Smiths Medical Ramps Up ParaPAC Ventilator Production For UK Order Of 10,000 Units

Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.

United Kingdom Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • CollaGenex Pharmaceuticals, Inc., Nestle S.A.
    • Nestle Skin Health S.A.
    • Spirig Pharma AG
UsernamePublicRestriction

Register